259 related articles for article (PubMed ID: 31607702)
1. Biological tailoring of adjuvant radiotherapy in head and neck and oral malignancies - The potential role of p53 and eIF4E as predictive parameters.
Joseph B; Kumar RV; Champaka G; Shenoy A; Sabitha KS; Lokesh V; Ramesh C; Vijay CR
Indian J Cancer; 2019; 56(4):330-334. PubMed ID: 31607702
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ
Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
[TBL] [Abstract][Full Text] [Related]
3. eIF4E and 4EBP1 are prognostic markers of head and neck squamous cell carcinoma recurrence after definitive surgery and adjuvant radiotherapy.
Huang CI; Wang CC; Tai TS; Hwang TZ; Yang CC; Hsu CM; Su YC
PLoS One; 2019; 14(11):e0225537. PubMed ID: 31756179
[TBL] [Abstract][Full Text] [Related]
4. An Australian retrospective study to evaluate the prognostic role of p53 and eIF4E cancer markers in patients with head and neck squamous cell carcinoma (HNSCC): study protocol.
Singh J; Jayaraj R; Baxi S; Mileva M; Curtin J; Thomas M
Asian Pac J Cancer Prev; 2013; 14(8):4717-21. PubMed ID: 24083732
[TBL] [Abstract][Full Text] [Related]
5. Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications.
Nathan CO; Sanders K; Abreo FW; Nassar R; Glass J
Cancer Res; 2000 Jul; 60(13):3599-604. PubMed ID: 10910074
[TBL] [Abstract][Full Text] [Related]
6. Analysis of eIF4E and 4EBP1 mRNAs in head and neck cancer.
Sunavala-Dossabhoy G; Palaniyandi S; Clark C; Nathan CO; Abreo FW; Caldito G
Laryngoscope; 2011 Oct; 121(10):2136-41. PubMed ID: 21898433
[TBL] [Abstract][Full Text] [Related]
7. Detection of the proto-oncogene eIF4E in larynx and hypopharynx cancers.
Franklin S; Pho T; Abreo FW; Nassar R; De Benedetti A; Stucker FJ; Nathan CO
Arch Otolaryngol Head Neck Surg; 1999 Feb; 125(2):177-82. PubMed ID: 10037284
[TBL] [Abstract][Full Text] [Related]
8. Outcome of Patients With Head and Neck Squamous Cell Carcinoma Can be Predicted by Expression of eIF4E and Osteopontin in Free Surgical Margins.
Abouhashem NS; Elwan A; Elaidy NF
Appl Immunohistochem Mol Morphol; 2022 May-Jun 01; 30(5):e40-e49. PubMed ID: 35285458
[TBL] [Abstract][Full Text] [Related]
9. Analysis of surgical margins with the molecular marker eIF4E: a prognostic factor in patients with head and neck cancer.
Nathan CO; Franklin S; Abreo FW; Nassar R; De Benedetti A; Glass J
J Clin Oncol; 1999 Sep; 17(9):2909-14. PubMed ID: 10561370
[TBL] [Abstract][Full Text] [Related]
10.
Joseph S; Janakiraman R; Chacko G; Jayaraj R; Thomas M; Thomas M; Mukhopadhyay S
BMJ Open; 2017 Oct; 7(10):e014824. PubMed ID: 29038175
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant radiotherapy is not supported in patients with verrucous carcinoma of the oral cavity.
Mohan S; Pai SI; Bhattacharyya N
Laryngoscope; 2017 Jun; 127(6):1334-1338. PubMed ID: 28150306
[TBL] [Abstract][Full Text] [Related]
12. Improvement in survival of patients with oral cavity squamous cell carcinoma: An international collaborative study.
Amit M; Yen TC; Liao CT; Chaturvedi P; Agarwal JP; Kowalski LP; Ebrahimi A; Clark JR; Kreppel M; Zöller J; Fridman E; Bolzoni VA; Shah JP; Binenbaum Y; Patel SG; Gil Z;
Cancer; 2013 Dec; 119(24):4242-8. PubMed ID: 24114787
[TBL] [Abstract][Full Text] [Related]
13. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.
Nathan CO; Amirghahari N; Abreo F; Rong X; Caldito G; Jones ML; Zhou H; Smith M; Kimberly D; Glass J
Clin Cancer Res; 2004 Sep; 10(17):5820-7. PubMed ID: 15355912
[TBL] [Abstract][Full Text] [Related]
14. p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma.
Shin DM; Lee JS; Lippman SM; Lee JJ; Tu ZN; Choi G; Heyne K; Shin HJ; Ro JY; Goepfert H; Hong WK; Hittelman WN
J Natl Cancer Inst; 1996 Apr; 88(8):519-29. PubMed ID: 8606380
[TBL] [Abstract][Full Text] [Related]
15. p53 and Ki-67 as markers of radioresistance in head and neck carcinoma.
Couture C; Raybaud-Diogène H; Têtu B; Bairati I; Murry D; Allard J; Fortin A
Cancer; 2002 Feb; 94(3):713-22. PubMed ID: 11857304
[TBL] [Abstract][Full Text] [Related]
16. Long term results of postoperative Intensity-Modulated Radiation Therapy (IMRT) in the treatment of Squamous Cell Carcinoma (SCC) located in the oropharynx or oral cavity.
Hoffmann M; Saleh-Ebrahimi L; Zwicker F; Haering P; Schwahofer A; Debus J; Huber PE; Roeder F
Radiat Oncol; 2015 Dec; 10():251. PubMed ID: 26637471
[TBL] [Abstract][Full Text] [Related]
17. Long-term experience with reduced planning target volume margins and intensity-modulated radiotherapy with daily image-guidance for head and neck cancer.
Chen AM; Yu Y; Daly ME; Farwell DG; Benedict SH; Purdy JA
Head Neck; 2014 Dec; 36(12):1766-72. PubMed ID: 24174221
[TBL] [Abstract][Full Text] [Related]
18. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
Rosenthal DI; Mohamed ASR; Garden AS; Morrison WH; El-Naggar AK; Kamal M; Weber RS; Fuller CD; Peters LJ
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1002-1011. PubMed ID: 28721881
[TBL] [Abstract][Full Text] [Related]
19. Implications of p53 over-expression in the outcome with radiation in head and neck cancers.
Lal P; Pal L; Kumar S; Dimri K; Tiwari A; Rastogi N; Singh S; Datta NR
J Cancer Res Ther; 2007; 3(1):17-22. PubMed ID: 17998714
[TBL] [Abstract][Full Text] [Related]
20. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
